+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Pain Patch Market Report: Trends, Forecast and Competitive Analysis to 2030

  • PDF Icon

    Report

  • 150 Pages
  • January 2024
  • Region: Global
  • Lucintel
  • ID: 5940963

Pain Patch Trends and Forecast

The future of the global pain patch market looks promising with opportunities in the online pharmacy, retail pharmacy, and hospital pharmacy markets. The global pain patch market is expected to reach an estimated $7.1 billion by 2030 with a CAGR of 4.8% from 2024 to 2030. The major drivers for this market are increasing prevalence of chronic pain and growing cases of sports and work related trauma injuries.

A more than 150-page report is developed to help in your business decisions.

Pain Patch by Segment

The study includes a forecast for the global pain patch by type, route of administration, therapeutic use, distribution channel, and region.

Pain Patch Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Opioid
  • Non-Opioid

Pain Patch Market by Route of Administration [Shipment Analysis by Value from 2018 to 2030]:

  • Metered Dose
  • Microneedle Patches

Pain Patch Market by Therapeutic Use [Shipment Analysis by Value from 2018 to 2030]:

  • Pain Relief
  • Anesthesia
  • Smoking Cessation
  • Cough Suppression
  • Diarrhea Suppression

Pain Patch Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

  • Online Pharmacies
  • Retail Pharmacies
  • Hospital Pharmacies
  • Others

Pain Patch Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Pain Patch Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies pain patch companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the pain patch companies profiled in this report include-
  • Teva Pharmaceutical Industries
  • Sorrento Therapeutics
  • Purdue Pharma
  • Grunenthal
  • Johnson and Johnson
  • Endo International
  • NEXGEL Advanced Hydrogel Solutions
  • Amneal Pharmaceuticals
  • Viatris
  • Hisamitsu Pharmaceutical

Pain Patch Market Insights

The report forecasts that non-opioid is expected to witness the higher growth over the forecast period due to its rising usage as an alternative of painkillers that can still effectively relieve symptoms without carrying the same risks.
Within this market, retail pharmacy will remain the largest segment due to its rising preference among people to obtain advice on prescription drugs and guidance on how to use them during treatment.
North America will remain the largest region over the forecast period due to availability of robust healthcare infrastructure and existence of major players in the region.

Features of the Global Pain Patch Market

  • Market Size Estimates: Pain patch market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
  • Segmentation Analysis: Pain patch market size by various segments, such as by type, route of administration, therapeutic use, distribution channel, and region in terms of value ($B).
  • Regional Analysis: Pain patch market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different type, route of administration, therapeutic use, distribution channel, and regions for the pain patch market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the pain patch market.
  • Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

FAQs

Q1. What is the pain patch market size?
Answer: The global pain patch market is expected to reach an estimated $7.1 billion by 2030.

Q2. What is the growth forecast for pain patch market?
Answer: The global pain patch market is expected to grow with a CAGR of 4.8% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the pain patch market?
Answer: The major drivers for this market are increasing prevalence of chronic pain and growing cases of sports and work related trauma injuries.

Q4. What are the major segments for pain patch market?
Answer: The future of the pain patch market looks promising with opportunities in the online pharmacy, retail pharmacy, and hospital pharmacy markets.

Q5. Who are the key pain patch market companies?

Answer: Some of the key pain patch companies are as follows:

  • Teva Pharmaceutical Industries
  • Sorrento Therapeutics
  • Purdue Pharma
  • Grunenthal
  • Johnson and Johnson
  • Endo International
  • NEXGEL Advanced Hydrogel Solutions
  • Amneal Pharmaceuticals
  • Viatris
  • Hisamitsu Pharmaceutical
Q6. Which pain patch market segment will be the largest in future?
Answer: The report forecasts that non-opioid is expected to witness the higher growth over the forecast period due to its rising usage as an alternative of painkillers that can still effectively relieve symptoms without carrying the same risks.

Q7. In pain patch market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to availability of robust healthcare infrastructure and existence of major players in the region.

Q.8 Do we receive customization in this report?
Answer: Yes, the publisher provides 10% customization without any additional cost.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the pain patch market by type (opioid and non-opioid), route of administration (metered dose and microneedle patches), therapeutic use (pain relief, anesthesia, smoking cessation, cough suppression, and diarrhea suppression), distribution channel (online pharmacies, retail pharmacies, hospital pharmacies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?


This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
2. Global Pain Patch Market: Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Pain Patch Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Pain Patch Market by Type
3.3.1: Opioid
3.3.2: Non-Opioid
3.4: Global Pain Patch Market by Route of Administration
3.4.1: Metered Dose
3.4.2: Microneedle Patches
3.5: Global Pain Patch Market by Therapeutic Use
3.5.1: Pain Relief
3.5.2: Anesthesia
3.5.3: Smoking Cessation
3.5.4: Cough Suppression
3.5.5: Diarrhea Suppression
3.6: Global Pain Patch Market by Distribution Channel
3.6.1: Online Pharmacies
3.6.2: Retail Pharmacies
3.6.3: Hospital Pharmacies
3.6.4: Others
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Pain Patch Market by Region
4.2: North American Pain Patch Market
4.2.1: North American Pain Patch Market by Type: Opioid and Non-Opioid
4.2.2: North American Pain Patch Market by Distribution Channel: Online Pharmacies, Retail Pharmacies, Hospital Pharmacies, and Others
4.3: European Pain Patch Market
4.3.1: European Pain Patch Market by Type: Opioid and Non-Opioid
4.3.2: European Pain Patch Market by Distribution Channel: Online Pharmacies, Retail Pharmacies, Hospital Pharmacies, and Others
4.4: APAC Pain Patch Market
4.4.1: APAC Pain Patch Market by Type: Opioid and Non-Opioid
4.4.2: APAC Pain Patch Market by Distribution Channel: Online Pharmacies, Retail Pharmacies, Hospital Pharmacies, and Others
4.5: ROW Pain Patch Market
4.5.1: ROW Pain Patch Market by Type: Opioid and Non-Opioid
4.5.2: ROW Pain Patch Market by Distribution Channel: Online Pharmacies, Retail Pharmacies, Hospital Pharmacies, and Others
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Pain Patch Market by Type
6.1.2: Growth Opportunities for the Global Pain Patch Market by Route of Administration
6.1.3: Growth Opportunities for the Global Pain Patch Market by Therapeutic Use
6.1.4: Growth Opportunities for the Global Pain Patch Market by Distribution Channel
6.1.5: Growth Opportunities for the Global Pain Patch Market by Region
6.2: Emerging Trends in the Global Pain Patch Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Pain Patch Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Pain Patch Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: Teva Pharmaceutical Industries
7.2: Sorrento Therapeutics
7.3: Purdue Pharma
7.4: Grunenthal
7.5: Johnson and Johnson
7.6: Endo International
7.7: NEXGEL Advanced Hydrogel Solutions
7.8: Amneal Pharmaceuticals
7.9: Viatris
7.10: Hisamitsu Pharmaceutical

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Teva Pharmaceutical Industries
  • Sorrento Therapeutics
  • Purdue Pharma
  • Grunenthal
  • Johnson and Johnson
  • Endo International
  • NEXGEL Advanced Hydrogel Solutions

Methodology

The analyst has been in the business of market research and management consulting since 2000 and has published over 600 market intelligence reports in various markets/applications and served over 1,000 clients worldwide. Each study is a culmination of four months of full-time effort performed by the analyst team. The analysts used the following sources for the creation and completion of this valuable report:

  • In-depth interviews of the major players in the market
  • Detailed secondary research from competitors’ financial statements and published data
  • Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
  • A compilation of the experiences, judgments, and insights of professionals, who have analyzed and tracked the market over the years.

Extensive research and interviews are conducted in the supply chain of the market to estimate market share, market size, trends, drivers, challenges and forecasts.

Thus, the analyst compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. The analyst then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process.

 

Loading
LOADING...